Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva Inks $450m Deals Over US Kickback Claims, Including Alleged Copay Violations

Oct 11 2024

• By Dean Rudge

Settlement newspaper headline on money — Teva is the seventh company to settle generic drug price fixing claims. • Source: Shutterstock

Related Content

Teva Pays Out $225m To Settle Criminal Price-Fixing Charges In US

Aug 22 2023

DoJ Copaxone Kickback Suit ‘Flawed’ And An ‘Overreach,’ Teva Says

Oct 22 2020

Glenmark Shells Out A Further $25m To Resolve Civil Price-Fixing Charges

Sep 05 2024

Sandoz, Apotex And Taro Strike Civil Settlements On Price-Fixing

Oct 04 2021

Related Companies

Teva Pharmaceutical Industries Ltd.

Glenmark Pharmaceuticals Limited

Sandoz Inc.

Apotex Inc.

Taro Pharmaceutical Industries Ltd.

Additional Topics

United States Legal Issues Reimbursement Regulation Enforcement Generic Drugs BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window